C
Christoph Hehrlein
Researcher at University of Freiburg
Publications - 69
Citations - 2345
Christoph Hehrlein is an academic researcher from University of Freiburg. The author has contributed to research in topics: Restenosis & Stent. The author has an hindex of 19, co-authored 67 publications receiving 2175 citations. Previous affiliations of Christoph Hehrlein include University Medical Center Freiburg.
Papers
More filters
Journal ArticleDOI
Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.
Bruno Scheller,Christoph Hehrlein,Wolfgang Bocksch,Wolfgang Rutsch,Dariush Haghi,Ulrich Dietz,Michael Böhm,Ulrich Speck +7 more
TL;DR: A randomized, double-blind, multicenter trial to compare the effects of a balloon catheter coated with paclitaxel (3 μg per square millimeter of balloon surface area) with those of an uncoated balloons catheter in coronary angioplasty found no significant differences.
Journal ArticleDOI
Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
Bruno Scheller,Christoph Hehrlein,Wolfgang Bocksch,Wolfgang Rutsch,Dariush Haghi,Ulrich Dietz,Michael Böhm,Ulrich Speck +7 more
TL;DR: Treatment of coronary ISR with paclitaxel-coated balloon catheters persistently reduces repeat restenosis up to 2 years and after a complete follow-up of 2 years.
Journal ArticleDOI
MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry.
Stephan Baldus,Wolfgang Schillinger,Olaf Franzen,Raffi Bekeredjian,Horst Sievert,Joachim Schofer,Karl-Heinz Kuck,Thomas Konorza,Helge Möllmann,Christoph Hehrlein,Taoufik Ouarrak,Jochen Senges,Thomas Meinertz +12 more
TL;DR: The acute outcomes of patients enrolled in the investigator‐initiated German transcatheter mitral valve interventions (TRAMI) registry are reported.
Journal ArticleDOI
Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.
Bruno Scheller,Yvonne P. Clever,Bettina Kelsch,Christoph Hehrlein,Wolfgang Bocksch,Wolfgang Rutsch,Dariush Haghi,Ulrich Dietz,Ulrich Speck,Michael Böhm,Bodo Cremers +10 more
TL;DR: Treatment of coronary ISR with paclitaxel-coated balloon catheters is safe and persistently reduces repeat revascularization during long-term follow-up.
Journal ArticleDOI
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial.
Henricus J. Duckers,Jaco H. Houtgraaf,Christoph Hehrlein,Joachim Schofer,Johannes Waltenberger,Anthony H. Gershlick,Jozef Bartunek,Christoph A. Nienaber,Carlos Macaya,Nicholas S. Peters,Peter Smits,Thomasz Siminiak,Walter van Mieghem,Victor Legrand,Patrick W. Serruys +14 more
TL;DR: Data indicate that implantation of myoblasts in patients with HF is feasible, appears to be safe and may provide symptomatic relief, though no significant effect was detected on global LVEF.